Ambev (ABEV) trades below the fair value estimate shown here. At $3.20 versus a $3.39 estimate, that is a 6% upside.
- Price
- $3.20
- Fair value estimate
- $3.39
- Upside
- +6%
- Forward P/E
- 12.0×
- Market cap
- $50.00B
- P/S (TTM)
- 3.1×
Overview
Ambev
Thesis
Key Metrics
Valuation
| Year | P/E | P/S | EV/EBITDA |
|---|---|---|---|
| FY22 | 2.6× | 0.5× | 1.1× |
| FY23 | 2.8× | 0.5× | 1.2× |
| FY24 | 2.0× | 0.3× | 0.1× |
| FY25 | 2.5× | 0.4× | 0.8× |
| TTM · | 17.1× | 0.6× | 1.3× |
| Ticker | Mkt Cap | P/E | P/S | EV/EBITDA | Rev Growth | Gross Mgn | Net Mgn |
|---|---|---|---|---|---|---|---|
| ABEV | $50.43B | 17.1× | 0.6× | 1.3× | 0.0% | 51.0% | 18.0% |
| KOF | $22.55B | – | 0.1× | 4.0× | +1.0% | 46.0% | 8.0% |
| FMX | $43.04B | 27.6× | 0.1× | 2.5× | +6.0% | 41.0% | 3.0% |
| BUD | $157.64B | 23.0× | 2.6× | 51.9× | +12.0% | 56.0% | 12.0% |
| TAP | $7.67B | – | 0.7× | 5.7× | +2.0% | 39.0% | -19.0% |
| STZ | $25.41B | 15.4× | 2.8× | 10.9× | -11.0% | 52.0% | 18.0% |
Financials
| Line Item | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Total Revenue | 79,709 | 79,737 | 89,453 | 88,242 |
| Cost of Revenue | 40,422 | 39,292 | 43,615 | 42,864 |
| Gross Profit | 39,287 | 40,445 | 45,838 | 45,378 |
| Operating Income | 17,403 | 18,773 | 21,507 | 22,323 |
| EBITDA | 23,085 | 24,270 | 29,012 | 28,974 |
| Net Income | 14,458 | 14,502 | 14,437 | 15,503 |
| Diluted EPS | 0.93 | 0.92 | 0.91 | 0.93 |
| Line Item | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Cash & Equivalents | 14,926 | 16,059 | 28,596 | 18,638 |
| Total Assets | 137,958 | 132,644 | 162,508 | 145,087 |
| Total Debt | 3,845 | 3,501 | 3,453 | 3,387 |
| Total Liabilities | 54,630 | 52,500 | 62,928 | 56,312 |
| Shareholders' Equity | 81,956 | 78,969 | 98,642 | 87,914 |
| Shares Out. (M) | 15,742 | 15,749 | 15,728 | 15,617 |
| Line Item | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Operating Cash Flow | 20,642 | 24,711 | 26,099 | 24,450 |
| Capital Expenditure | (6,533) | (6,004) | (4,749) | (4,590) |
| Free Cash Flow | 14,109 | 18,707 | 21,350 | 19,860 |
| Investing Cash Flow | (5,004) | (5,766) | (5,463) | (4,950) |
| Financing Cash Flow | (16,338) | (16,115) | (10,352) | (26,772) |
Catalysts
Risks
| Risk | Category | Severity | Probability | Impact on Thesis |
|---|---|---|---|---|
| BRL depreciation vs USD | Market/Macro | Medium | High | Erodes USD-translated earnings and the dividend. |
| Low structural growth | Competition | Medium | High | Mature beer category limits multiple expansion. |
| Brazil tax/regulatory regime | Regulatory | Low | Medium | Dividend-withholding and excise changes can reduce net cash returns to nonresidents. |
Technical Snapshot
Ownership & Insider Activity
| Institution | Shares | % Held | Chg QoQ | Filing |
|---|---|---|---|---|
| First Eagle Investment Management, LLC | 347.0M | 2.20% | +3.2% | 2026-03-31 |
| GQG Partners LLC | 187.0M | 1.19% | +8.1% | 2026-03-31 |
| Blackrock Inc. | 34.9M | 0.22% | +43.2% | 2026-03-31 |
| Seafarer Capital Partners, LLC | 28.1M | 0.18% | flat | 2026-03-31 |
| Renaissance Technologies, LLC | 27.4M | 0.17% | +6.5% | 2026-03-31 |
| Massachusetts Financial Services Co. | 26.5M | 0.17% | -24.1% | 2026-03-31 |
| Brandes Investment Partners L.P. | 23.1M | 0.15% | +2.1% | 2026-03-31 |
| Name | Title | Action | Shares | Price | Date | Value |
|---|---|---|---|---|---|---|
| Zagman Paulo Andre | See Remarks | Sell | 136.2K | $3.41 | 2026-05-05 | $464.6K |
| Cavalcanti De Lacerda Eduardo Braga | See Remarks | Sell | 152.4K | $2.85 | 2026-03-27 | $434.3K |
| Malik Parente Guilherme | See Remarks | Sell | 21K | $2.76 | 2026-03-24 | $57.9K |
Peer Comparison
| Ticker | Mkt Cap | P/E | P/S | EV/EBITDA | Rev Growth | Gross Mgn | Net Mgn |
|---|---|---|---|---|---|---|---|
| ABEV | $50.43B | 17.1× | 0.6× | 1.3× | 0.0% | 51.0% | 18.0% |
| KOF | $22.55B | – | 0.1× | 4.0× | +1.0% | 46.0% | 8.0% |
| FMX | $43.04B | 27.6× | 0.1× | 2.5× | +6.0% | 41.0% | 3.0% |
| BUD | $157.64B | 23.0× | 2.6× | 51.9× | +12.0% | 56.0% | 12.0% |
| TAP | $7.67B | – | 0.7× | 5.7× | +2.0% | 39.0% | -19.0% |
| STZ | $25.41B | 15.4× | 2.8× | 10.9× | -11.0% | 52.0% | 18.0% |
Research Notes
Ambev valuation questions
Is Ambev (ABEV) stock undervalued?
Against the fair value estimate shown on this page, Ambev trades below: $3.20 today versus a $3.39 estimate, about +6%. The methodology and per-scenario sources are set out in the Valuation section. Treat it as research, not advice, and do your own homework.
What is Ambev's fair value?
The fair value estimate shown for ABEV is $3.39. Its valuation scenarios span bear $2.60, base $3.39, bull $4.00. See the Valuation section for the basis of each.
What is Ambev's forward P/E ratio?
Ambev (ABEV) trades at a forward P/E of 12.0×, and 3.1× trailing sales.
What is Ambev's market cap?
Ambev (ABEV) has a market capitalization (its market value, often searched as "net worth") of $50.00B, and an enterprise value of $46.00B.
What is the bull and bear case for ABEV?
Valuation scenarios: bull $4.00, base $3.39, bear $2.60. Each reflects a distinct set of assumptions; the drivers and sources are detailed in the Valuation section above.